Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-15

Clinical Trial Update: All-Case Surveillance of Prizbind®

View source ↗

Summary

All-case surveillance study update for Prizbind®, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prizbind®

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hemorrhage | Status: COMPLETED | Results posted: 2021-12-15